497
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers

, , , , , & show all
Pages 1703-1709 | Accepted 09 Apr 2008, Published online: 12 May 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sri Harsha Tella & Marc S Rendell. (2015) DPP-4 inhibitors: focus on safety. Expert Opinion on Drug Safety 14:1, pages 127-140.
Read now
Elisa Guarino, Laura Nigi, Aurora Patti, Cecilia Fondelli & Francesco Dotta. (2012) Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 13:9, pages 1377-1384.
Read now
Mary Elizabeth Cox, Jennifer Rowell, Leonor Corsino & Jennifer B Green. (2010) Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy. Drug, Healthcare and Patient Safety 2, pages 7-19.
Read now
Chantal Mathieu & Evy Degrande. (2008) Vildagliptin: a new oral treatment for type 2 diabetes mellitus. Vascular Health and Risk Management 4:6, pages 1349-1360.
Read now

Articles from other publishers (11)

LiJun Ye, Bei Li, NengMing Ling, Yue Gao, XueXia Tao, ShuFan Cai, Yan Wang, ShaoChun Chen & Fei Wang. (2021) Pharmacokinetics and Bioequivalence of a Generic Fixed‐Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting Conditions. Clinical Pharmacology in Drug Development 11:1, pages 63-70.
Crossref
Ziye Zhou, Chenxiang Wang, Min Li, Qin Lan, Chao Yu, Guoxin Yu, Yan Xia, Huafang Chen & Xiuhua Zhang. (2020) In Vitro Dissolution and In Vivo Bioequivalence Evaluation of Two Metformin Extended‐Release Tablets. Clinical Pharmacology in Drug Development 10:4, pages 414-419.
Crossref
Konstantin Savateev, Victor Fedotov, Ilya Butorin, Oleg Eltsov, Pavel Slepukhin, Evgeny Ulomsky, Vladimir Rusinov, Roman Litvinov, Denis Babkov, Elisaveta Khokhlacheva, Pyotr Radaev, Pavel Vassiliev & Alexandr Spasov. (2020) Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents. European Journal of Medicinal Chemistry 185, pages 111808.
Crossref
E. V Sokolova, E. A Hohlacheva, D. D SHamshina, A. E Batychyok, P. A Radaev, N. A Prokof'eva, R. A Litvinov, D. A Babkov, K. V. Savateev & V. V. Fedotov. (2019) ANTIGLYCATION AND DPP-4 INGIBITION ACTIVITY OF NOVEL AZOLEAZINE-DERIVED COMPOUNDS. Journal of Volgograd State Medical University 16:1, pages 79-82.
Crossref
Gillian M. Keating. (2014) Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus. Drugs 74:5, pages 587-610.
Crossref
Garry G. Graham, Jeroen Punt, Manit Arora, Richard O. Day, Matthew P. Doogue, Janna K. Duong, Timothy J. Furlong, Jerry R. Greenfield, Louise C. Greenup, Carl M. Kirkpatrick, John E. Ray, Peter Timmins & Kenneth M. Williams. (2011) Clinical Pharmacokinetics of Metformin. Clinical Pharmacokinetics 50:2, pages 81-98.
Crossref
Gillian M. Keating. (2010) Vildagliptin. Drugs 70:16, pages 2089-2112.
Crossref
A. J. Scheen. (2010) Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes, Obesity and Metabolism 12:8, pages 648-658.
Crossref
Jing Wu, Yiding Chen, Xiaoli Shi & Wei Gu. (2009) Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes. Journal of Nanjing Medical University 23:4, pages 228-235.
Crossref
Abd A. Tahrani, Milan K. Piya & Anthony H. Barnett. (2009) Drug evaluation: Vildagliptin-metformin single-tablet combination. Advances in Therapy 26:2, pages 138-154.
Crossref
Jamie D Croxtall & Susan J Keam. (2008) Vildagliptin. Drugs 68:16, pages 2387-2409.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.